Washington: In a landmark agreement, AstraZeneca CEO Pascal Soriot stood alongside U.S. President Donald Trump in the Oval Office on Friday as the Anglo-Swedish pharmaceutical giant finalized a medicine deal that promises to lower drug prices for millions of Americans. This marks the first time a non-U.S. drugmaker has secured such an arrangement while avoiding the threat of steep import tariffs in the world’s largest pharmaceutical market.

The deal comes after months of strategic negotiations, including private meetings with Trump officials and high-profile engagements with U.S. politicians. Soriot’s diplomatic efforts included attending a royal banquet at Windsor Castle, multiple discussions with U.S. Secretary of Commerce Howard Lutnick, and fostering a strong rapport with Virginia G

See Full Page